(Q40603028)

22 September 2017

1 reference

title

Prognostic factors in myeloma: what they tell us about the pathophysiology of the disease (English)

1 reference

22 September 2017

Joshua DE

1

1 reference

22 September 2017

Brown RD

series ordinal

2

1 reference

22 September 2017

Gibson J

series ordinal

3

1 reference

22 September 2017

publication date

1 November 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

15

1 reference

22 September 2017

issue

5-6

1 reference

22 September 2017

page(s)

375-381

1 reference

CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre Origin

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

B-cell surface phenotypes of proliferating myeloma cells: target antigens for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Nephrotoxic potential of Bence Jones proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

High serum IL-2 levels are predictive of prolonged survival in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049739

10.3109/10428199409049739

21 January 2018

Identifiers

DOI

1 reference

release_zxjouo5dvzetxkodlwzkapahv4

22 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zxjouo5dvzetxkodlwzkapahv4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference